PRINCETON, NJ — Oyster Point Pharma Inc., a pharmaceutical company developing therapies for dry eye disease, has raised $93 million in funding.
Tattoo Design Website $93M Raised for Dry Eye Drug Development - Invision Mag Tattoo Design Website
PRINCETON, NJ — Oyster Point Pharma Inc., a pharmaceutical company developing therapies for dry eye disease, has raised $93 million in funding.
5 Biggest Surprises In The New GMAC Prospective Student Data Poets&Quants from "MBA" - Google News Online Degree Program...
No comments:
Post a Comment